RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY

被引：0
|
作者：
Von Allwoerden, K. [1 ]
Klapa, S. [1 ]
Werth, S. C. [2 ]
Mueller, A. [1 ]
Riemekasten, G. [1 ]
Nitschke, M. [2 ]
Thaci, D. [3 ]
Lamprecht, P. [1 ]
机构：
[1] Univ Lubeck, Rheumatol, Lubeck, Germany
[2] Univ Lubeck, Nephrol, Lubeck, Germany
[3] Univ Lubeck, Entzundungsmed, Lubeck, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Real-world evidence; Quality of care; Vasculitis;
D O I：
10.1136/annrheumdis-2023-eular.3867
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1161
引用
收藏
页码：912 / 913
页数：2
相关论文
共 50 条
  • [41] Rituximab Immunogenicity in ANCA-associated Vasculitis (RITUXIMAV)
    Springer, Jason
    Funk, Ryan
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [42] Rituximab or Azathioprine Maintenance in ANCA-Associated Vasculitis
    Vandergheynst, Frederic
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04): : 385 - 386
  • [43] Extending the Indications for Rituximab in ANCA-Associated Vasculitis
    Jayne, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (19): : 1839 - 1840
  • [44] Single dose of rituximab for ANCA-associated vasculitis
    Nature Reviews Rheumatology, 2014, 10 (5) : 258 - 258
  • [45] Rituximab for ANCA-associated vasculitis: The UK experience
    Jayne, David
    PRESSE MEDICALE, 2013, 42 (04): : 532 - 534
  • [46] Comment on: Induction treatment of ANCA-associated vasculitis with a single dose of rituximab
    Moog, Philipp
    Schulze-Koops, Hendrik
    Thuermel, Klaus
    RHEUMATOLOGY, 2015, 54 (02) : 372 - 373
  • [47] DETERMINANTS OF RITUXIMAB PHARMACOKINETICS AND REMISSION INDUCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Cornec, Divi
    Kabat, Brian F.
    Mills, John R.
    Cheu, Melissa
    Hummel, Amber M.
    Schroeder, Darrell R.
    Cascino, Matthew D.
    Brunetta, Paul
    Murray, David L.
    Snyder, Melissa R.
    Fervenza, Fernando
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    Clair, E. William St.
    Stone, John H.
    Barnidge, David R.
    Specks, Ulrich
    RHEUMATOLOGY, 2017, 56 : 154 - 154
  • [48] Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis
    Miloslavsky, E.
    Specks, U.
    Merkel, P.
    Seo, P.
    Spiera, R.
    Langford, C.
    Hoffman, G.
    Kallenberg, C.
    St Clair, W.
    Tchao, N.
    Ding, L.
    Ikle, D.
    Jepson, B.
    Brunetta, P.
    Stone, J.
    PRESSE MEDICALE, 2013, 42 (04): : 779 - 780
  • [49] RITUXIMAB FOR INDUCTION THERAPY OF ANCA-ASSOCIATED RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS
    Tomilina, Natalia
    Biryukova, Ludmila
    Volgina, Galina
    Frolova, Nadia
    Stolyarevich, Ekaterina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [50] Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
    Smith, Rona M.
    Jones, Rachel Bronwen
    Specks, Ulrich
    Bond, Simon
    Nodale, Marianna
    Aljayyousi, Reem
    Andrews, Jacqueline
    Bruchfeld, Annette
    Camilleri, Brian
    Carette, Simon
    Cheung, Chee Kay
    Derebail, Vimal
    Doulton, Tim
    Forbess, Lindsy
    Fujimoto, Shouichi
    Furuta, Shunsuke
    Gewurz-Singer, Ora
    Harper, Lorraine
    Ito-Ihara, Toshiko
    Khalidi, Nader
    Klocke, Rainer
    Koening, Curry
    Komagata, Yoshinori
    Langford, Carol
    Lanyon, Peter
    Luqmani, Raashid Ahmed
    Makino, Hirofumi
    McAlear, Carole
    Monach, Paul
    Moreland, Larry W.
    Mynard, Kim
    Nachman, Patrick
    Pagnoux, Christian
    Pearce, Fiona
    Peh, Chen Au
    Pusey, Charles
    Ranganathan, Dwarakanathan
    Rhee, Rennie L.
    Spiera, Robert
    Sreih, Antoine G.
    Tesar, Vladimir
    Walters, Giles
    Weisman, Michael H.
    Wroe, Caroline
    Merkel, Peter
    Jayne, David
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) : 1243 - 1249
12345